FTQGX
Price
$39.00
Change
+$0.47 (+1.22%)
Updated
Jul 9 closing price
Net Assets
4.07B
GFACX
Price
$70.77
Change
+$0.64 (+0.91%)
Updated
Jul 9 closing price
Net Assets
320.6B
Interact to see
Advertisement

FTQGX vs GFACX

Header iconFTQGX vs GFACX Comparison
Open Charts FTQGX vs GFACXBanner chart's image
Fidelity Focused Stock
Price$39.00
Change+$0.47 (+1.22%)
VolumeN/A
Net Assets4.07B
American Funds Growth Fund of Amer C
Price$70.77
Change+$0.64 (+0.91%)
VolumeN/A
Net Assets320.6B
FTQGX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTQGX vs. GFACX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTQGX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 321B vs. FTQGX (4.07B). FTQGX pays higher dividends than GFACX: FTQGX (0.33) vs GFACX (0.00). FTQGX was incepted earlier than GFACX: FTQGX (29 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FTQGX (0.61). FTQGX is a more actively managed with annual turnover of: 105.00 vs. GFACX (25.00). FTQGX has a lower initial minimum investment than GFACX: FTQGX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 8.26 vs. FTQGX (-4.56). GFACX return over 5 years is better than : 34.52 vs. FTQGX (32.13).
FTQGXGFACXFTQGX / GFACX
Total Expense Ratio0.611.3645%
Annual Report Gross Expense Ratio0.611.3645%
Fund Existence29 years24 years-
Gain YTD1.77010.99416%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.07B321B1%
Annual Yield % from dividends0.330.00-
Returns for 1 year-4.568.26-55%
Returns for 3 years46.3148.7495%
Returns for 5 years32.1334.5293%
Returns for 10 years98.1067.62145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLRB4.850.15
+3.19%
Cellectar Biosciences Inc
UNF171.901.27
+0.74%
Unifirst Corp
CHCT16.670.01
+0.06%
Community Healthcare Trust
THTX3.14N/A
N/A
Theratechnologies
RCI32.15-0.10
-0.31%
Rogers Communications